Table 1 Baseline characteristics and anesthetic agents received (all-subjects-treated group)
Chinese | Caucasian | |||
|---|---|---|---|---|
Sugammadex (n = 120) | Neostigmine (n = 111) | Sugammadex (n = 29) | Neostigmine (n = 31) | |
Gender (n, %) | ||||
Female | 78 (65) | 86 (77) | 25 (86) | 28 (90) |
Male | 42 (35) | 25 (23) | 4 (14) | 3 (10) |
Race (n, %) | ||||
White | 0 (0) | 0 (0) | 29 (100) | 31 (100) |
Asian | 120 (100) | 111 (100) | 0 (0) | 0 (0) |
Age (Mean, SD years) | 39.9 (10.8) | 39.4 (10.8) | 52.0 (10.3) | 51.9 (7.3) |
Weight (Mean, SD kg) | 62.8 (12.6) | 61.3 (11.3) | 72.8 (10.8) | 72.7 (11.8) |
Height (Mean, SD cm) | 163.8 (7.7) | 163.7 (6.7) | 169.1 (6.6) | 167.9 (6.8) |
BMI (mean, SD kg/m2) | 23.3 (3.6) | 22.8 (3.3) | 25.5 (3.5) | 25.9 (4.3) |
ASA class (n, %) | ||||
1 | 90 (75) | 82 (74) | 12 (41) | 16 (52) |
2 | 28 (23) | 29 (26) | 15 (52) | 15 (48) |
3 | 2 (2) | 0 (0) | 2 (7) | 0 (0) |
Anesthetic agents received (n, %) | ||||
Propofol | 120 (100) | 111 (100) | 29 (100) | 31 (100) |
Remifentanil | 101 (84) | 92 (83) | 20 (69) | 23 (74) |
Fentanyl | 65 (54) | 66 (59) | 7 (24) | 10 (32) |
Sufentanyl | 41 (34) | 38 (34) | 9 (31) | 8 (26) |
Tramadol | 2 (2) | 3 (3) | 0 (0) | 0 (0) |
Butorphanol | 0 (0) | 1 (1) | 0 (0) | 0 (0) |